Effects of the marine macrolides swinholide A and jasplakinolide on outflow facility in monkeys

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 13, 2001, Pages 3187-3192

  Tian, Baohe ^a   Kiland, Julie A ^a   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; FUSED HETEROCYCLIC RINGS; JASPAMIDE; LATRUNCULIN B; MARINE TOXIN; SWINHOLIDE A; THIAZOLE DERIVATIVE;

ANIMAL; ANTERIOR EYE CHAMBER; ARTICLE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; MACACA; PHYSIOLOGY;

ANIMAL; ANTERIOR CHAMBER; BICYCLO COMPOUNDS, HETEROCYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; MACACA FASCICULARIS; MARINE TOXINS; PEPTIDES, CYCLIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THIAZOLES;

EID: 0035653464     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kobayashi M, Tanaka J, Katori T, Matsuura M, Yamashita M, Kitagawa I. Marine natural products. XXII. The absolute stereostructure of swinholide A, a potent cytotoxic dimeric macrolide from the okinawan marine sponge Theonella swinhoei. Chem Pharm Bull. 1990;38:2409-2418.
2. Todd JS, Alvi KA, Crews P. The isolation of a monomeric carboxylic acid of swinholide A from the indo-pacific sponge, Theonella swinhoei. Tetrahedron Lett. 1992;33:441-442.
3. Carmely S, Kashman Y. Structure of swinholide-A, a new macrolide from the marine sponge Theonella swinhoei. Tetrahedron Lett. 1985;26:511-514.
4. Kobayashi M, Kawazoe K, Okamoto T, Sasaki T, Kitagawa I. Marine natural products. XXXI. Structure-activity correlation of a potent cytotoxic dimeric macrolide swinholide A, from the okinawan marine sponge Theonella swinhoei, and its isomers. Chem Pharm Bull. 1994;42:19-26.
5. Bubb MR, Spector I, Bershadsky AD, Korn ED. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J Biol Chem. 1995;270:3463-3466.
6. Bubb MR, Spector I. Use of the F-actin-binding drugs, misakinolide A and swinholide A. Methods Enzymol. 1998;298:26-32.
7. Saito S, Watabe S, Ozaki H, et al. Actin-depolymerizing effect of dimeric macrolides, bistheonellide A and swinholide A. J Biochem. 1998;123:571-578.
8. Lyubimova A, Bershadsky AD, Ben-Ze'ev A. Autoregulation of actin synthesis responds to monomeric actin levels. J Cell Biochem. 1997;65:469-478.
9. Spector I, Shochet NR, Kashman Y, Groweiss A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science. 1983;219:493-495.
10. Coué M, Brenner SL, Spector I, Korn ED. Inhibition of actin polymerization by latrunculin A. FEBS Lett. 1987;213:316-318.
11. Peterson JA, Tian B, Bershadsky AD, et al. Latrunculin-A increases outflow facility in the monkey. Invest Ophthalmol Vis Sci. 1999;40:931-941.
12. Peterson JA, Tian B, Geiger B, Kaufman PL. Effect of latrunculin-B on outflow facility in monkeys. Exp Eye Res. 2000;70:307-313.
13. Peterson JA, Tian B, McLaren JW, Hubbard WC, Geiger B, Kaufman PL. Latrunculin effects on intraocular pressure, aqueous humor flow and corneal endothelium. Invest Ophthalmol Vis Sci. 2000;41:1749-1758.
14. Crews P, Manes LV, Boehler M. Novel sponge derived amino acids. 1: jasplakinolide, a cyclodepsipeptide from the marine sponge Jaspis sp. Tetrahedron Lett. 1986;27:2797-2800.
15. Zabriskie TM, Klocke JA, Ireland CM, et al. Jaspamide, a modified peptide from Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc. 1986;108:3123-3124.
16. Stingl J, Anderson RJ, Emerman JT. In vitro screening of crude extracts and pure metabolites obtained from marine invertebrates for the treatment of breast cancer. Cancer Chemother Pharmacol. 1992;30:401-406.
17. Scott VR, Boehme R, Matthews TR. New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrob Agents Chemother. 1988;32:1154-1157.
18. Bubb MR, Senderowicz AMJ, Sausville EA, Duncan KLK, Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem. 1994;269:14869-14871.
19. Brenner SL, Korn ED. Substoichiometric concentrations of cytochalasin D inhibit actin polymerization: additional evidence for an F-actin treadmill. J Biol Chem. 1979;254:9982-9985.
20. Kaufman PL, Erickson KA. Cytochalasin B, and D dose-outflow facility response relationships in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1982;23:646-650.
21. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74-81.
22. Robinson JC, Kaufman PL. Phalloidin inhibits epinephrine's and Cytochalasin B's facilitation of aqueous outflow. Arch Ophthalmol. 1994;112:1610-1613.
23. Morris A, Tannenbaum J. Cytochalasin D does not produce net depolymerization of actin filaments in Hep-2 cells. Nature. 1980;287:637-639.
24. Bershadsky AD, Glück U, Denisenko ON, Sklyarova TV, Spector I, Ben-Ze'ev A. The state of actin assembly regulates actin and vinculin expression by a feedback loop, J Cell Sci. 1995;108:1183-1193.
25. Bárány EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
26. Bárány EH. Relative importance of autonomic nervous tone and structure as determinants of outflow resistance in normal monkey eyes (Cercopithecus ethiops and Macaca irus). In: Rohen JW, ed. The Structure of the Eye, Second Symposium. Stuttgart: FK Schattauer Verlag; 1965:223-236.
27. Serpinskaya AS, Denisenko ON, Gelfand VI, Bershadsky AD. Stimulation of actin synthesis in phalloidin-treated cells. FEBS Lett. 1990;277:11-14.
28. Reuner KH, Schlegel K, Just I, Katz N. Autoregulatory control of actin synthesis in cultured rat hepatocytes. FEBS Lett. 1991;286:100-104.
29. Reuner KH, Wiederhold M, Schlegel K, Just I, Katz N. Autoregulation of actin synthesis by physiological alterations of the G-actin level in hepatocytes. Eur J Clin Chem Clin Biochem. 1995;33:569-574.
30. Bubb MR, Spector I, Beyer BB, Fosen KM. Effects of jasplakinolide on the kinetics of actin polymerization. J Biol Chem. 2000;275:5163-5170.
31. Senderowicz AM, Kaur G, Sainz E, et al. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J Natl Cancer Inst. 1995;87:46-51.
32. Spector I, Braet F, Shochet NR, Bubb MR. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech. 1999;47:18-37.
33. Cramer LP. Role of actin-filament disassembly in lamellipodium protrusion in motile cells revealed using the drug jasplakinolide. Curr Biol. 1999;9:1095-1105.
34. Rotsch C, Radmacher M. Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study. Biophys J. 2000;78:520-535.
35. Tian B, Gabelt BT, Geiger B, Kaufman PL. Combined effects of H-7 and cytochalasin B on outflow facility in monkeys. Exp Eye Res. 1999;68:649-655.
36. Tian B, Brumback LC, Kaufman PL. ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey eye. Exp Eye Res. 2000;71:551-566.